GSK poaches key vaccine executive from Pfizer
GlaxoSmithKline has poached a key vaccine executive from Pfizer, as the UK drugmaker makes a big bet on the future of mRNA technology. Philip Dormitzer will this week join GSK as global head of vaccines research and development, leaving the…